Sign in

NCT05480865CompletedPhase 1

A Phase 1 Study of the SHP2 Inhibitor BBP-398 (formerly known as IACS-15509) in combination with the KRAS-G12C Inhibitor Sotorasib in Patients with Advanced Solid Tumors and a KRAS-G12C Mutation

Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 May 2024

Status (registry)
Completed
Phase (registry)
Phase 1
Study type
Interventional
Enrollment
75 (actual)
First submitted
2 Sept 2022
Start date
17 Mar 2023
Lead sponsor
Navire Pharma Inc.
Diseases
Lung cancer
NCT number
NCT05480865
EU CT number
2022-501363-40-00

What you commit to

  • Study type: Interventional · Phase 1
  • Participants enrolled: 75
  • 27 sites in 7 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Sites (27)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Grand Hopital de Charleroi
Coordinator of this site? Confirm its status
CharleroiBelgiumCompleted
CHU de Liège
Coordinator of this site? Confirm its status
LiègeBelgiumCompleted
Rigshospitalet
Coordinator of this site? Confirm its status
Copenhagen OeDenmarkCompleted
Hospital Quirónsalud Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
Hospital Universitari Vall d'Hebron
Coordinator of this site? Confirm its status
BarcelonaSpainCompleted
University Clinic of Navarra
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital General Universitario Gregorio Marañón
Coordinator of this site? Confirm its status
MadridSpainCompleted
Hospital Universitario Virgen de la Victoria
Coordinator of this site? Confirm its status
MálagaSpainCompleted
Hospital Universitario Quironsalud Madrid
Coordinator of this site? Confirm its status
Pozuelo de AlarcónSpainCompleted
Hospital Universitario Virgen De La Macarena
Coordinator of this site? Confirm its status
SevillaSpainCompleted
Institut Bergonie
Coordinator of this site? Confirm its status
BordeauxFranceCompleted
Centr Georges Francois Leclerc
Coordinator of this site? Confirm its status
DijonFranceCompleted
Centre Hospitalier Universitaire Grenoble Alpes
Coordinator of this site? Confirm its status
Grenoble Cedex 9FranceCompleted
Centre Oscar Lambret
Coordinator of this site? Confirm its status
LilleFranceCompleted
Assistance Publique Hopitaux De Paris
Coordinator of this site? Confirm its status
Paris Cedex 18FranceCompleted
Centre Hospitalier Universitaire de Rennes
Coordinator of this site? Confirm its status
RennesFranceCompleted
Thoracic General Hospital of Athens "I Sotiria"
Coordinator of this site? Confirm its status
AthensGreeceCompleted
University General Hospital Attikon
Coordinator of this site? Confirm its status
AthensGreeceCompleted
University General Hospital of Heraklion
Coordinator of this site? Confirm its status
HeraklionGreeceCompleted
Athens Medical Center S.A. - The European Interbalkan Medical Center in Thessaloniki
Coordinator of this site? Confirm its status
ThessalonikiGreeceCompleted
St. Luke's Hospital S.A.
Coordinator of this site? Confirm its status
ThessalonikiGreeceCompleted
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Coordinator of this site? Confirm its status
BresciaItalyCompleted
Careggi University Hospital
Coordinator of this site? Confirm its status
FlorenceItalyCompleted
Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli
Coordinator of this site? Confirm its status
NaplesItalyCompleted
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Coordinator of this site? Confirm its status
NaplesItalyCompleted
Netherlands Cancer Institute
Coordinator of this site? Confirm its status
AmsterdamNetherlandsCompleted
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Coordinator of this site? Confirm its status
RotterdamNetherlandsCompleted

This page is information, not medical advice. Discuss any trial with your doctor.